Skip to content

Effects of Virtual Reality on Dual Task Performance

The Investigation of the Effects of Virtual Reality Training on Dual Task Performance, Balance and Gait on Patients With Chronic Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03845855
Enrollment
30
Registered
2019-02-19
Start date
2019-02-20
Completion date
2019-06-11
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

virtual reality, stroke, dual task

Brief summary

This study evaluates the effects of virtual reality treatment in addition to robotic gait therapy on dual task performance, balance and gait in chronic stroke patients. Half of participants will attend virtual reality treatment in addition to robotic gait therapy for 12 sessions, while the other half will attend only robotic gait therapy for 12 sessions.

Detailed description

Following stroke, motor disorders, balance disorders, falls, gait disturbances and cognitive disorders are frequently seen. In stroke rehabilitation, with the use of robots and virtual reality systems with conventional methods, it is aimed to increase patient's motivation, to check if exercise is effective, to provide objective evaluation data and to support the motor learning process and the use of these methods in the field of neurological rehabilitation is increasing. Multi-task evaluations can be made with the virtual environments created by virtual reality applications and complex tasks. The traditional approach to stroke rehabilitation is mainly focused on balance and gait training under single task conditions. In everyday life, people should not only have balance and mobility skills, but also have the ability to perform other cognitive and motor tasks with these skills. Therefore, traditional approaches are not sufficient for the individual to return to society after a stroke. In this respect, this study was planned in order to examine the effects of frequently used virtual reality treatment in addition to robotic gait therapy on the dual task, balance and gait performance.

Interventions

OTHERvirtual reality

Virtual reality with a game

OTHERrobotic gait

robotic gait therapy

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Volunteer to participate in the research * Stroke for the first time * To be able to walk independently before the disease * To score 3 or above in the functional ambulation classification * 6 months after stroke diagnosis * Not having open wounds * Severity of spasticity of the lower extremities to be 3 and below according to the Modified Asworth Scale * To score 24 or more in the Mini Mental State Examination

Exclusion criteria

* Acute internal problems, additional neurological diseases, or orthopedic problems that might limit walking * To have received botulinum toxin treatment during 6 months before treatment or during treatment * To have stroke on both sides * To have neglect

Design outcomes

Primary

MeasureTime frameDescription
10 meter walk testchange from baseline time at the end of 6 weekThe time is measured after 10 meter walk completed
10 meter walk test with cognitive taskchange from baseline time at the end of 6 weekThe time is measured after 10 meter walk with a cognitive task completed
10 meter walk test with motor taskchange from baseline time at the end of 6 weekThe time is measured after 10 meter walk with a motor task completed

Secondary

MeasureTime frameDescription
Berg Balance Scalechange from baseline score at the end of 6 weekThe Berg balance scale is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function.
Mini Mental State Examinationchange from baseline score at the end of 6 weekMini Mental State Examination can be used to assess the mental status. Mini Mental State Examination is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The maximum score is 30. The minimum score is 0. Getting 24 point is cut point. If a person get 24 points from examination, his/her mental status is fine. The higher scores represent better mental status.
Functional Gait Assessmentchange from baseline score at the end of 6 weekThe Funcitonal Gait Assessment is used to assess postural stability during various walking tasks. The highest score is 30/30. Higher scores represent better functional gait performance.
Falls Efficacy Scale - Internationalchange from baseline score at the end of 6 weekThe Falls Efficacy Scale International are measures of fear of falling or, more properly, concerns about falling. Minimum 16 (no concern about falling) to maximum 64 (severe concern about falling) can be obtained.
Functional Ambulation Classificationchange from baseline score at the end of 6 weekThis 6-point scale assesses ambulation status by determining how much human support the patient requires when walking, regardless of whether or not they use a personal assistive device. Level 0 is the minimum level and level 5 is the maximum level. Higher levels represent better function.
Rivermead Mobility Indexchange from baseline score at the end of 6 weekRivermead Mobility Index assesses functional mobility in gait, balance and transfers after stroke. 14-self-reported items and 1 direct observation item are calculated. Items are coded as either 0 or 1, depending on whether the patient can complete the task according to specific instructions. Items receive a score of 0 for a No response and 1 for a Yes response.A maximum of 15 points is possible; higher scores indicate better mobility performance.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026